Anti-proliferation and pro-apoptosis effects of miR-582-5p in chronic lymphocytic leukemia via targeting HNRNPA1 and suppression of NF-κB
Authors:
- 1 June 2021
- journal article
- research article
- Published by Springer Nature in Molecular & Cellular Toxicology
- Vol. 17 (3) , 357-365
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF‐κB activation – functional relevance of predicted PDZ domain–motif interactionThe FEBS Journal, 2014
- NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategiesImmunity & Ageing, 2013
- miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genesCarcinogenesis, 2012
- MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia CellsPLOS ONE, 2011
- MicroRNAs in CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markersBlood, 2008
- hnRNP A1 regulates UV-induced NF-κB signalling through destabilization of cIAP1 mRNACell Death & Differentiation, 2008
- Shared Principles in NF-κB SignalingCell, 2008
- NF‐κB activation in development and progression of cancerCancer Science, 2007
- Interaction between hnRNPA1 and IκBα Is Required for Maximal Activation of NF-κB-Dependent TranscriptionMolecular and Cellular Biology, 2001